Inotiv Inc (NOTV)
4.27
+0.11
(+2.64%)
USD |
NASDAQ |
May 03, 16:00
4.27
0.00 (0.00%)
After-Hours: 20:00
Inotiv Revenue (Quarterly): 135.50M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 135.50M |
September 30, 2023 | 140.74M |
June 30, 2023 | 157.47M |
March 31, 2023 | 151.46M |
December 31, 2022 | 122.75M |
September 30, 2022 | 150.47M |
June 30, 2022 | 172.67M |
March 31, 2022 | 140.31M |
December 31, 2021 | 84.21M |
September 30, 2021 | 30.08M |
June 30, 2021 | 22.89M |
March 31, 2021 | 18.75M |
December 31, 2020 | 17.88M |
September 30, 2020 | 15.77M |
June 30, 2020 | 15.76M |
March 31, 2020 | 16.01M |
December 31, 2019 | 12.92M |
September 30, 2019 | 14.79M |
June 30, 2019 | 10.86M |
March 31, 2019 | 9.344M |
December 31, 2018 | 8.625M |
September 30, 2018 | 8.986M |
June 30, 2018 | 6.039M |
March 31, 2018 | 5.944M |
December 31, 2017 | 5.377M |
Date | Value |
---|---|
September 30, 2017 | 5.873M |
June 30, 2017 | 5.836M |
March 31, 2017 | 6.359M |
December 31, 2016 | 6.174M |
September 30, 2016 | 5.154M |
June 30, 2016 | 5.053M |
March 31, 2016 | 5.339M |
December 31, 2015 | 4.895M |
September 30, 2015 | 4.977M |
June 30, 2015 | 6.15M |
March 31, 2015 | 5.726M |
December 31, 2014 | 5.845M |
September 30, 2014 | 6.42M |
June 30, 2014 | 6.032M |
March 31, 2014 | 5.912M |
December 31, 2013 | 6.22M |
September 30, 2013 | 5.508M |
June 30, 2013 | 5.60M |
March 31, 2013 | 5.156M |
December 31, 2012 | 5.803M |
September 30, 2012 | 6.54M |
June 30, 2012 | 7.186M |
March 31, 2012 | 6.966M |
December 31, 2011 | 7.516M |
September 30, 2011 | 8.153M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
10.86M
Minimum
Jun 2019
172.67M
Maximum
Jun 2022
75.33M
Average
30.08M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
Avid Bioservices Inc | 33.82M |
Macrogenics Inc | 9.164M |
Synlogic Inc | 2.769M |
BioXcel Therapeutics Inc | 0.376M |
IGM Biosciences Inc | 0.651M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -15.39M |
Total Expenses (Quarterly) | 143.77M |
EPS Diluted (Quarterly) | -0.60 |
Enterprise Value | 467.47M |
Gross Profit Margin (Quarterly) | 24.70% |
Profit Margin (Quarterly) | -11.36% |
Earnings Yield | -30.44% |
Operating Earnings Yield | 4.96% |
Normalized Earnings Yield | -26.30 |